GI
MIRM icon

GAMMA Investing’s Mirum Pharmaceuticals MIRM Stock Holding History

GAMMA Investing’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.1K Buy
368
+35
+11% +$3.51K ﹤0.01% 2399
2026
Q1 		$30.8K Buy
333
+31
+10% +$2.92K ﹤0.01% 2488
2025
Q4 		$23.9K Buy
302
+83
+38% +$5.96K ﹤0.01% 2517
2025
Q3 		$16.1K Buy
219
+74
+51% +$4.7K ﹤0.01% 2638
2025
Q2 		$7.38K Buy
145
+21
+17% +$935 ﹤0.01% 2960
2025
Q1 		$5.59K Buy
124
+4
+3% +$189 ﹤0.01% 3043
2024
Q4 		$4.96K Buy
120
+61
+103% +$2.54K ﹤0.01% 2922
2024
Q3 		$2.3K Buy
59
+49
+490% +$1.96K ﹤0.01% 3028
2024
Q2 		$342 Sell
10
-7
-41% -$184 ﹤0.01% 3263
2024
Q1 		$427 Buy
+17
New +$467 ﹤0.01% 3128

Other funds holding MIRM

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return

GAMMA Investing's MIRM Position: Q2 2026 in Review

GAMMA Investing increased its Mirum Pharmaceuticals (MIRM) stake by 11% in Q2 2026, buying an estimated $3.51K and bringing the position to 368 shares worth $43.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2399.

GAMMA Investing first reported a position in MIRM in Q1 2024 and has held it in 10 quarters since. 22 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • GAMMA Investing held 368 shares of Mirum Pharmaceuticals worth $43.1K as of Q2 2026.
  • GAMMA Investing bought 35 Mirum Pharmaceuticals shares in Q2 2026, an estimated $3.51K.
  • Mirum Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2399 holding.
  • GAMMA Investing first reported a position in Mirum Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 22 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.